| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.53B | 10.71B | 10.67B | 10.85B | 9.59B | 8.53B |
| Gross Profit | 4.20B | 4.34B | 4.03B | 3.92B | 3.85B | 3.79B |
| EBITDA | 1.25B | 1.40B | 1.33B | 1.05B | 1.53B | 1.33B |
| Net Income | 415.00M | 542.00M | 442.00M | 352.00M | 829.00M | 630.00M |
Balance Sheet | ||||||
| Total Assets | 14.17B | 14.25B | 14.56B | 14.74B | 13.88B | 13.18B |
| Cash, Cash Equivalents and Short-Term Investments | 1.57B | 1.47B | 1.78B | 1.79B | 1.21B | 1.86B |
| Total Debt | 0.00 | 5.37B | 5.56B | 5.88B | 3.55B | 2.89B |
| Total Liabilities | 9.79B | 9.43B | 10.01B | 10.19B | 8.24B | 7.23B |
| Stockholders Equity | 4.17B | 4.57B | 4.32B | 4.33B | 5.42B | 5.75B |
Cash Flow | ||||||
| Free Cash Flow | 480.00M | 367.00M | 840.00M | -29.00M | 317.00M | 962.00M |
| Operating Cash Flow | 814.00M | 673.00M | 1.13B | 263.00M | 605.00M | 1.22B |
| Investing Cash Flow | -261.00M | -132.00M | -144.00M | -1.09B | -134.00M | -427.00M |
| Financing Cash Flow | -24.00M | -684.00M | -827.00M | 1.14B | -974.00M | -353.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $6.71B | 28.11 | 9.40% | 1.16% | 3.87% | -10.30% | |
72 Outperform | $85.45B | 33.66 | 59.94% | 0.92% | 0.96% | 1.96% | |
69 Neutral | $13.85B | 20.17 | 24.05% | 1.93% | 3.09% | 12.25% | |
67 Neutral | $21.88B | 17.40 | 16.31% | 2.85% | -12.98% | -11.34% | |
62 Neutral | $17.09B | ― | -0.46% | 120.64% | 2.42% | -196.54% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | $11.60B | 236.10 | 1.03% | 3.38% | -0.12% | -91.96% |
Akzo Nobel is a leading global paints and coatings company, known for its innovative products and sustainable solutions in the decorative paints and performance coatings sectors. In its latest earnings report for the third quarter of 2025, Akzo Nobel highlighted a challenging financial landscape, with a 5% decline in revenue primarily due to adverse currency effects, despite a 1% increase in organic sales driven by price/mix improvements. The company faced a significant setback with a €29 million negative operating income, largely attributed to a €275 million provision for a long-running Australian court case. Adjusted EBITDA stood at €385 million, slightly down from the previous year, but the EBITDA margin improved to 15.1% due to efficiency measures. Akzo Nobel’s net cash from operating activities was robust at €331 million, reflecting effective cash management. Looking ahead, Akzo Nobel remains cautiously optimistic, aiming for an adjusted EBITDA of around €1.48 billion for the full year 2025, with plans to enhance profitability and maintain a strong investment-grade credit rating.